Mastering Chronic Disease Management: The Role of Implantable Pressure Sensors in MedTech

Long-term reliable pressure data has long been a goal for physicians and a challenge for medical device companies. While smarter, sensor-based medical devices for acute applications have enabled healthcare professionals to generate quantifiable data for more accurate diagnoses and improved treatment decisions, the same level of innovation has yet to be fully realized in chronic applications until now.

Millar’s TiSense is a novel technology platform featuring a MEMS piezoresistive sensor integrated into a chronic implantable module, designed for implantation periods of greater than 5 years. This cutting-edge solution has the potential to transform chronic disease management by providing long-term, continuous pressure monitoring, supporting proactive care, and improving patient outcomes.

Join us as we explore how implantable pressure sensors are shaping the future of MedTech. We’ll discuss the latest advancements, including the benefits of MEMS sensors for long-term applications and the exciting potential of implantable sensors in chronic disease management.